Phase 2 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 80 years old, of any sex
- People who have been diagnosed with kidney cancer (particularly a type called clear cell renal cell carcinoma), lymphoma, or nasopharyngeal carcinoma (a type of cancer affecting the back of the nose and throat), either confirmed by a tissue sample or suspected based on medical imaging
- People who are able to give their agreement to take part and are willing to follow the requirements of the trial
Who may not be able to join:
- People who are pregnant
- People with severe problems affecting how their liver or kidneys work
- People who have had an allergic reaction to a type of imaging drug made from single-domain antibodies (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianjun Liu, Ph.D. & M.D., Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Phone: 15000083153
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The uptake patterns of CD70-targeted tracers across different tumors; The diagnostic value of CD70-targeted immunoPET/CT across different tumors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.